Cardinal Health PT Raised to $64.00 (CAH)
Robert W. Baird raised their price objective on shares of Cardinal Health (NYSE:CAH) from $60.00 to $64.00 in a research note issued on Monday, Analyst RN reports. The firm currently has an “outperform” rating on the stock. Robert W. Baird’s price target would indicate a potential upside of 18.83% from the company’s current price.
Cardinal Health (NYSE:CAH) traded up 0.02% on Monday, hitting $53.86. 2,020,194 shares of the company’s stock traded hands. Cardinal Health has a 52 week low of $38.76 and a 52 week high of $53.96. The stock’s 50-day moving average is $51.82 and its 200-day moving average is $48.02. The company has a market cap of $18.283 billion and a P/E ratio of 55.69.
Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, August 1st. The company reported $0.79 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.77 by $0.02. The company had revenue of $25.40 billion for the quarter, compared to the consensus estimate of $24.56 billion. During the same quarter last year, the company posted $0.73 earnings per share. Cardinal Health’s revenue was down 5.0% compared to the same quarter last year. On average, analysts predict that Cardinal Health will post $3.58 earnings per share for the current fiscal year.
CAH has been the subject of a number of other recent research reports. Analysts at Zacks upgraded shares of Cardinal Health from a “neutral” rating to an “outperform” rating in a research note to investors on Friday. They now have a $64.00 price target on the stock. Separately, analysts at Credit Suisse raised their price target on shares of Cardinal Health from $58.00 to $60.00 in a research note to investors on Thursday. They now have an “outperform” rating on the stock. Finally, analysts at Sterne Agee initiated coverage on shares of Cardinal Health in a research note to investors on Thursday, September 19th. They set a “neutral” rating and a $48.00 price target on the stock. Three analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. Cardinal Health has an average rating of “Buy” and a consensus target price of $53.93.
Cardinal Health, Inc is a healthcare services company providing products and services that help pharmacies, hospitals, surgery centers, physician offices and other healthcare providers.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.